Featured

https://www.benzinga.com/markets/cannabis/22/05/27124788/exclusive-nasdaq-listed-enveric-to-split-into-two-companies-one-for-cannabinoids-one-for-psyched

CEO Update: Enveric to Spin-off and Dividend Cannabinoid Pipeline to Shareholders   Dr. Joseph Tucker, CEO of Enveric Biosciences, details the Company’s plan to spin-off its #cannabinoid clinical development pipeline assets to a wholly-owned subsidiary, Acanna Therapeutics Inc. Following the spin-off, the resulting stand-alone public companies will focus their resources on the R&D of each […]

Enveric Biosciences – The Psybrary   Enveric is focused on creating a library of novel derivative molecules based on classic psychedelics.